- Home
- REXR vs LNTH Comparison
REXR vs LNTH Comparison
Compare REXR & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REXR
- LNTH
- Stock Information
- Founded
- REXR 2013
- LNTH 1956
- Country
- REXR United States
- LNTH United States
- Employees
- REXR N/A
- LNTH N/A
- Industry
- REXR Real Estate Investment Trusts
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- REXR Real Estate
- LNTH Health Care
- Exchange
- REXR Nasdaq
- LNTH Nasdaq
- Market Cap
- REXR 7.7B
- LNTH 7.5B
- IPO Year
- REXR 2013
- LNTH 2015
- Fundamental
- Price
- REXR $35.71
- LNTH $81.24
- Analyst Decision
- REXR Hold
- LNTH Strong Buy
- Analyst Count
- REXR 9
- LNTH 5
- Target Price
- REXR $42.11
- LNTH $133.80
- AVG Volume (30 Days)
- REXR 2.3M
- LNTH 1.4M
- Earning Date
- REXR 04-16-2025
- LNTH 05-07-2025
- Dividend Yield
- REXR 4.81%
- LNTH N/A
- EPS Growth
- REXR 12.67
- LNTH N/A
- EPS
- REXR 1.23
- LNTH 3.53
- Revenue
- REXR $974,598,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- REXR $9.99
- LNTH $4.96
- Revenue Next Year
- REXR $8.93
- LNTH $10.25
- P/E Ratio
- REXR $29.07
- LNTH $23.00
- Revenue Growth
- REXR 18.04
- LNTH 12.53
- 52 Week Low
- REXR $29.68
- LNTH $74.34
- 52 Week High
- REXR $52.61
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- REXR 57.07
- LNTH 32.82
- Support Level
- REXR $34.78
- LNTH $77.01
- Resistance Level
- REXR $36.55
- LNTH $83.60
- Average True Range (ATR)
- REXR 0.74
- LNTH 3.77
- MACD
- REXR 0.42
- LNTH -2.21
- Stochastic Oscillator
- REXR 80.33
- LNTH 13.26
About REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.